News

In our Medical News section, you'll find up-to-date and relevant information on the latest advances in the field of health. This space is designed to keep you informed about research, clinical developments, and evidence-based science.

HIV pre-exposure prophylaxis programs are progressing slowly in Latin America

By Matías A. Loewy Although 24 countries in Latin America and the Caribbean now have pre-exposure prophylaxis (PrEP) programs against the human immunodeficiency virus, and the number of users belonging to "key" vulnerable populations, such as men who have sex with men, transgender women, and sex workers, tripled between 2020 and 2022, progress…

Read more

What do you know about the oral and genital herpes virus?

By Liz Highleyman. Herpes simplex refers to conditions caused by two related viruses that result in painful blisters. Herpes is difficult to prevent, treat, and cure, but scientists are working on vaccines and better medications. Oral herpes (cold sores or fever blisters), which affects the lips and mouth, is usually caused by…

Read more

A new antibiotic could fight multidrug-resistant superbugs

By Aude Lecrubier. Antibiotic resistance is a major public health problem. Few new molecules are being developed, but a new antibiotic called clovibactin offers hope. This drug, isolated from bacteria that have not been studied until now, appears to be able to combat multidrug-resistant “superbugs” thanks to unusual mechanisms of action. The drug was…

Read more

The FDA authorizes a new COVID-19 vaccine

Damian McNamara, MA The FDA today authorized the newest COVID-19 vaccine, the first that doesn't target the original or "ancestral" strain of the virus. Last year, the FDA authorized a bivalent vaccine targeting both the old and new strains. This time, it's a "monovalent" or single-strain vaccine with…

Read more

Do you know how Grindr can affect your FOMO?

By Pedro Serrano. FOMO comes from an English acronym, 'Fear Of Missing Out', which translates to the fear of missing out on something. That feeling of wanting to do or be somewhere different from where we are. Deep down, it comes from the sense of belonging that we all have. The fear of being excluded from the group. Belonging to something. Being part of…

Read more

The FDA approves the treatment for multidrug-resistant HIV

By Viviana Sofía Flores Rivera, Yale University. The FDA has approved lenacapavir injection for the treatment of multidrug-resistant HIV. HIV is not yet curable, but it can be successfully treated throughout a person's life. "And that's why, in the field, we want to make sure that the treatments we have, which for…

Read more

How to properly assess the patient and what recommendations to follow when prescribing exercise for primary prevention?

News and Perspectives > Medscape Medical News > ACC LATAM 2023 Dr. Natalia Martínez Medina The American Heart Association (AHA) recommends at least 150 minutes of moderate-intensity aerobic activity per week, 75 minutes of vigorous-intensity aerobic activity per week, or a combination of both, preferably spread throughout the week, to prevent cardiovascular disease. How well do physicians prescribe exercise and how…

Read more

New recommendation expands guidance on antiretroviral drugs for HIV

Brian Owens The U.S. Preventive Services Task Force (USPSTF) is expanding its recommendations for antiretroviral drugs for HIV now that more options are available. “With these new options, we could extend pre-exposure prophylaxis (PrEP) to a broader population,” says James Stevermer, MD, a member of the task force…

Read more

33 arrested, the inquisition in the age of AI

Last Monday, July 24, 2023, thirty-three adult men were arrested for allegedly "having group sex in a private establishment." But this is not a matter of recounting the events, because it is more than clear that this arrest represents a flagrant violation of individual rights, since…

Read more

Lenacapavir demonstrates safety and efficacy for one year

By John Parkinson. The twice-yearly injection proved beneficial in conjunction with an optimized background regimen. People with multidrug-resistant (MDR) HIV have limited therapy options, which can make managing their disease very challenging. And there are only a couple of treatment options for these patients…

Read more

Doravirine/islatravir is as effective as Biktarvy in previously untreated individuals

Keith Alcorn - A combination of the non-nucleoside reverse transcriptase inhibitor doravirine and the experimental antiretroviral islatravir proved as effective as the combination of bictegravir, emtricitabine, and tenofovir alafenamide (Biktarvy) in suppressing HIV in previously untreated individuals after 48 weeks of treatment, reported Professor Jürgen Rockstroh of the University…

Read more

Sixth case of HIV "cure" after a bone marrow transplant

The Pasteur Institute (France) and the University Hospitals of Geneva (Switzerland) will present a new case of HIV "cure" following a bone marrow transplant. This is the sixth patient cured of the virus, known as the "Geneva patient." This new milestone will be presented at the IAS International Conference. Details of a third case were published in February in the scientific journal "Nature Medicine"...

Read more
1 2 3 4 5 6 7 8 9 10